glp-1 employer healthcare costs Perspectives from employers on the and issues associated with covering agonists for weight loss Employers Weighing the Obesity Drug

This suggests that amongst other things, the Ghrelin suppression we mentioned in the previous article is dropping as the Incretin on board (IOB) drops

(2002), published in Journal of the American Academy of Dermatology, 71 women with photoaged skin applied a GHK-Cu-containing facial cream daily

NICE Clinical Knowledge Summary (CKS) and NHS guidance emphasise the importance of addressing both reproductive and metabolic aspects of PCOS through lifestyle modification, pharmacological intervention when appropriate, and regular screening for associated comorbidities, including periodic HbA1c or glucose tolerance testing and lipid monitoring

At minimum, track weekly weight

Doctors are booked out months in advance, even for their regular patients, so even just starting the process can waste time you could be using to lose weight